In this episode of Superbugs Unplugged, our guest, Dr. Erin Duffy, discusses the global health threat of antimicrobial resistance (AMR), and why and how her non-profit, CARB-X, is investing in diverse products to help overcome common challenges faced in Low- and Middle-Income Countries (LMICs). Dr. Duffy is the Chief of R&D at CARB-X, a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat resistant bacterial
infections. Prior to CARB-X, Dr. Duffy served as Chief Scientific Officer of Melinta Therapeutics.